Seattle Genetics, Inc. is a clinical-stage biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The Company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize the product candidate...
Your Rating
You must submit at least one review.
Review successfully posted.
You will shortly receive an email to confirm your review.
Currently no review was submitted for this company. Share your experiences with this company!